PRECIGEN, INC. Operating Expenses
PRECIGEN, INC. (PGEN) reported Operating Expenses of $32.34 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-04
- PRECIGEN, INC. operating expenses for the quarter ending 2026-06-30 was $32.34M, a 0.87% decline year-over-year.
- PRECIGEN, INC. operating expenses for the quarter ending 2026-03-31 was $29.25M, a 22.18% increase year-over-year.
- PRECIGEN, INC. operating expenses for the quarter ending 2025-06-30 was $32.62M.
- PRECIGEN, INC. operating expenses for the quarter ending 2025-03-31 was $23.94M.
- PRECIGEN, INC. operating expenses for fiscal 2025 was $120.19M, a 13.50% decline from fiscal 2024.
- PRECIGEN, INC. operating expenses for fiscal 2024 was $138.95M, a 31.11% increase from fiscal 2023.
- PRECIGEN, INC. operating expenses for fiscal 2023 was $105.98M.
- PRECIGEN, INC. operating expenses for fiscal 2018 was $666.18M, a 80.60% increase from fiscal 2017.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $32.34M 10-Q · filed 2026-08-04 | $61.58M 10-Q · filed 2026-08-04 | |||||
| 2026-03-31 | $29.25M 10-Q · filed 2026-05-13 | ||||||
| 2025-12-31 | $120.19M 10-K · filed 2026-03-25 | ||||||
| 2025-06-30 | $32.62M 10-Q · filed 2026-08-04 | $56.56M 10-Q · filed 2026-08-04 | |||||
| 2025-03-31 | $23.94M 10-Q · filed 2026-05-13 | ||||||
| 2024-12-31 | $138.95M 10-K · filed 2026-03-25 | ||||||
| 2023-12-31 | $105.98M 10-K · filed 2026-03-25 | ||||||
| 2019-09-30 | $71.66M 10-Q · filed 2019-11-12 | $145.06M derived: sum of 2 quarters · filed 2019-11-12 | $227.09M 10-Q · filed 2019-11-12 | $607.16M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2019-06-30 | $73.39M 10-Q · filed 2019-08-09 | $155.43M 10-Q · filed 2019-08-09 | $535.50M derived: sum of 3 quarters · filed 2019-08-09 | $634.42M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2019-03-31 | $82.04M 10-Q · filed 2019-05-09 | $462.11M derived: sum of 2 quarters · filed 2019-05-09 | $561.02M derived: sum of 3 quarters · filed 2019-11-12 | $656.03M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-12-31 | $380.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $478.99M derived: sum of 2 quarters · filed 2019-11-12 | $574.00M derived: sum of 3 quarters · filed 2019-11-12 | $666.18M 10-K · filed 2019-03-01 | |||
| 2018-09-30 | $98.92M 10-Q · filed 2019-11-12 | $193.93M derived: sum of 2 quarters · filed 2019-11-12 | $286.12M 10-Q · filed 2019-11-12 | $389.77M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | $95.01M 10-Q · filed 2019-08-09 | $187.20M 10-Q · filed 2019-08-09 | $290.85M derived: sum of 3 quarters · filed 2019-08-09 | $381.61M derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | $92.32M 10-Q · filed 2019-05-09 | $195.84M derived: sum of 2 quarters · filed 2019-05-09 | $286.60M derived: sum of 3 quarters · filed 2019-05-09 | $376.30M derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | $103.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $194.28M derived: sum of 2 quarters · filed 2019-03-01 | $283.99M derived: sum of 3 quarters · filed 2019-03-01 | $368.87M 10-K · filed 2019-03-01 | |||
| 2017-09-30 | $90.76M 10-Q · filed 2018-11-08 | $180.47M derived: sum of 2 quarters · filed 2018-11-08 | $265.35M 10-Q · filed 2018-11-08 | $344.19M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-06-30 | $89.70M 10-Q · filed 2018-08-13 | $174.59M 10-Q · filed 2018-08-13 | $253.42M derived: sum of 3 quarters · filed 2019-03-01 | $331.23M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-03-31 | $85.13M 10-Q/A · filed 2018-08-13 | $163.72M derived: sum of 2 quarters · filed 2019-03-01 | $241.53M derived: sum of 3 quarters · filed 2019-03-01 | $317.25M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | $78.59M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $156.40M derived: sum of 2 quarters · filed 2019-03-01 | $232.12M derived: sum of 3 quarters · filed 2019-03-01 | $316.09M 10-K · filed 2019-03-01 | |||
| 2016-09-30 | $77.81M 10-Q · filed 2017-11-09 | $153.53M derived: sum of 2 quarters · filed 2017-11-09 | $237.50M 10-Q · filed 2017-11-09 | $313.39M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $75.72M 10-Q · filed 2017-08-09 | $159.69M 10-Q · filed 2017-08-09 | $235.59M derived: sum of 3 quarters · filed 2018-03-01 | $296.87M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | $83.97M 10-Q · filed 2017-05-10 | $159.86M derived: sum of 2 quarters · filed 2018-03-01 | $221.15M derived: sum of 3 quarters · filed 2018-03-01 | $283.47M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $75.89M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $137.18M derived: sum of 2 quarters · filed 2018-03-01 | $199.50M derived: sum of 3 quarters · filed 2018-03-01 | $320.47M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | $61.28M 10-Q · filed 2016-11-09 | $123.60M derived: sum of 2 quarters · filed 2016-11-09 | $244.58M 10-Q · filed 2016-11-09 | $294.63M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $62.32M 10-Q · filed 2016-08-09 | $183.29M 10-Q · filed 2016-08-09 | $233.35M derived: sum of 3 quarters · filed 2017-03-01 | $269.59M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $120.97M 10-Q · filed 2016-05-10 | $171.03M derived: sum of 2 quarters · filed 2017-03-01 | $207.27M derived: sum of 3 quarters · filed 2017-03-01 | $237.14M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $50.05M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $86.30M derived: sum of 2 quarters · filed 2017-03-01 | $116.17M derived: sum of 3 quarters · filed 2017-03-01 | $141.89M 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $36.24M 10-Q · filed 2015-11-09 | $66.11M derived: sum of 2 quarters · filed 2015-11-09 | $91.84M 10-Q · filed 2015-11-09 | $116.71M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $29.87M 10-Q · filed 2015-08-10 | $55.59M 10-Q · filed 2015-08-10 | $80.46M derived: sum of 3 quarters · filed 2016-02-29 | $98.63M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $25.73M 10-Q · filed 2015-05-11 | $50.59M derived: sum of 2 quarters · filed 2016-02-29 | $68.77M derived: sum of 3 quarters · filed 2016-02-29 | $89.71M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $24.87M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $43.04M derived: sum of 2 quarters · filed 2016-02-29 | $63.98M derived: sum of 3 quarters · filed 2016-02-29 | $81.78M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | $18.08M 10-Q · filed 2014-11-13 | $39.11M derived: sum of 2 quarters · filed 2014-08-14 | $56.91M 10-Q · filed 2014-11-13 | $57.19M 10-Q · filed 2013-11-07 | $75.81M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-06-30 | $20.94M 10-Q · filed 2014-08-14 | $21.04M 10-Q/A · filed 2013-10-21 | $38.84M 10-Q · filed 2014-08-14 | $39.02M 10-Q/A · filed 2013-10-21 | $57.64M derived: sum of 3 quarters · filed 2015-03-02 | $77.05M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-03-31 | $17.89M 10-Q · filed 2014-05-09 | $36.70M derived: sum of 2 quarters · filed 2015-03-02 | $56.11M derived: sum of 3 quarters · filed 2015-03-02 | $80.08M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-12-31 | $18.81M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $38.22M derived: sum of 2 quarters · filed 2015-03-02 | $62.19M derived: sum of 3 quarters · filed 2015-03-02 | $88.93M 10-K · filed 2015-03-02 | |||
| 2012-09-30 | $19.41M 10-Q · filed 2013-11-07 | $43.38M derived: sum of 2 quarters · filed 2013-11-07 | $70.12M 10-Q · filed 2013-11-07 | ||||
| 2012-06-30 | $23.97M 10-Q/A · filed 2013-10-21 | $50.71M 10-Q/A · filed 2013-10-21 | |||||
| 2011-12-31 | $90.44M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |